ProfileGDS4718 / 227841_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 64% 64% 70% 67% 66% 66% 75% 68% 70% 62% 67% 64% 68% 60% 62% 65% 61% 62% 57% 68% 67% 66% 65% 62% 63% 66% 65% 67% 64% 62% 58% 70% 67% 64% 69% 65% 68% 70% 63% 68% 64% 59% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6894168
GSM549102patient 115, normal, homogenized [OPG study]6.4317764
GSM549104patient 119, normal, homogenized [OPG study]6.4643564
GSM549108patient 138, normal, homogenized [OPG study]6.80370
GSM549119patient 077, normal, homogenized [OPG study]6.6049867
GSM549133patient 032, cancer, homogenized [OPG study]6.578166
GSM549139patient 042, cancer, homogenized [OPG study]6.5277266
GSM549099patient 107, normal, homogenized [OPG study]7.2100975
GSM549109patient 139, normal, homogenized [OPG study]6.6816468
GSM549110patient 046, normal, homogenized [OPG study]6.8612970
GSM549114patient 063, normal, homogenized [OPG study]6.2438862
GSM549122patient 082, normal, homogenized [OPG study]6.634567
GSM549134patient 033, cancer, homogenized [OPG study]6.4007264
GSM549136patient 036, cancer, homogenized [OPG study]6.7264268
GSM549140patient 044, cancer, homogenized [OPG study]6.1098260
GSM549111patient 047, normal, homogenized [OPG study]6.2711962
GSM549113patient 057, normal, homogenized [OPG study]6.4775465
GSM549132patient 031, cancer, homogenized [OPG study]6.1931561
GSM549137patient 038, cancer, homogenized [OPG study]6.2717162
GSM549142patient 047, cancer, homogenized [OPG study]6.0391557
GSM549100patient 110, normal, homogenized [OPG study]6.7041668
GSM549107patient 135, normal, homogenized [OPG study]6.6577767
GSM549115patient 068, normal, homogenized [OPG study]6.5307766
GSM549116patient 072, normal, homogenized [OPG study]6.5075165
GSM549120patient 078, normal, homogenized [OPG study]6.2299762
GSM549131patient 030, cancer, homogenized [OPG study]6.3343363
GSM549118patient 074, normal, homogenized [OPG study]6.5391266
GSM549129patient 027, cancer, homogenized [OPG study]6.5353165
GSM549123patient 088, normal, homogenized [OPG study]6.6134967
GSM549124patient 006, cancer, homogenized [OPG study]6.4176964
GSM549126patient 015, cancer, homogenized [OPG study]6.2725962
GSM549128patient 025, cancer, homogenized [OPG study]6.029958
GSM549103patient 117, normal, homogenized [OPG study]6.8510270
GSM549117patient 073, normal, homogenized [OPG study]6.59167
GSM549138patient 041, cancer, homogenized [OPG study]6.39564
GSM549141patient 045, cancer, homogenized [OPG study]6.9013469
GSM549130patient 028, cancer, homogenized [OPG study]6.4407465
GSM549101patient 111, normal, homogenized [OPG study]6.7556368
GSM549105patient 128, normal, homogenized [OPG study]6.8390970
GSM549106patient 134, normal, homogenized [OPG study]6.364763
GSM549112patient 048, normal, homogenized [OPG study]6.6710468
GSM549125patient 011, cancer, homogenized [OPG study]6.4243264
GSM549127patient 024, cancer, homogenized [OPG study]6.1380959
GSM549135patient 035, cancer, homogenized [OPG study]6.6535367